← Surfer · The Kit · Coach hub
Coach — Endocannabinoids (conservation · recovery)
The endocannabinoid system is usually discussed as a target for plant drugs. Its older job is quieter: it helps the body save energy, store surplus, protect itself under load, and recover afterward, provided the signal is allowed to switch off.
Safety first
This essay is about the body's own signaling system, not about cannabis. The extended report is plain about the line it draws: "It does not recommend, prescribe, or encourage the use of cannabis, tetrahydrocannabinol, cannabidiol, cannabigerol, or any other cannabinoid. Nothing in it is a protocol for training, fasting, supplementation, or self-experimentation."
It lists the risks directly: "Cannabinoids can impair attention, memory, coordination, and driving; alter sleep architecture; interact with prescription drugs; and are inappropriate in pregnancy, in adolescence, and in people with a history of psychosis, cannabis-use disorder, or unstable cardiovascular disease." On the law: "Cannabis and tetrahydrocannabinol are controlled substances under federal law in the United States and are restricted or prohibited in many other jurisdictions. Possession, purchase, and use may be illegal depending on location. Cannabidiol products vary in legality, purity, and labeled content. Legal status is the reader's responsibility."
And on the only setting in which outside modulation is even mentioned: "Exogenous ligands are not recommended on this site. If a clinician ever explores guided modulation, that conversation belongs with that clinician — dose, timing, cycling, and recovery criteria are not inventable from a web page."
Some situations call for a prompt conversation with a physician: worries about dependence, any history of psychosis, impaired driving or attention, broken sleep after use, or concerns about interactions with prescribed drugs. Attempts to schedule plant products around training, or to use them in place of recovery, are a reason to step back, not a plan.
Older than reward
Endocannabinoids are usually described as reward molecules, anti-inflammatory agents, or sleep promoters. Those are downstream roles. At its core, the system is built around two fatty messengers made from the cell's own membranes, anandamide and a molecule called 2-AG. They act mainly at a receptor called CB1, which sits on nerve endings throughout the body and also on the outer membrane of mitochondria themselves. The extended report reads the whole system as an ancient interface that links the body's energy status to four jobs: conserving energy, allocating surplus to storage, dampening demand to protect tissue, and running recovery afterward.
Native signaling has a particular shape. The messengers are made on demand, at the moment a cell is active, and they are broken down quickly by dedicated enzymes. The signal is local and brief. Continuous high tone with no recovery was never part of the design.
The report places this system beside two others discussed on the site. Adenosine is the fast signal of energy spent, the molecule that builds up as ATP is used and pushes toward rest. The nicotinic system amplifies demand. The cannabinoid system sits on the conservation and recovery side. All three report or shape some aspect of the cell's energy charge, and all three become adaptive only when they rise, fall, and are followed by recovery.
Why the system exists
Ancestral life meant intermittent loads and intermittent abundance. A body needed more than a brake and an accelerator. It needed a way to favor energy-dense food when it was available, to store surplus and avoid wasting heat, to quiet runaway firing in the nervous system before it burned through ATP, and to turn down mitochondrial output locally when output needed to match need or protect capacity. The report calls this thrifty logic: building stores for future needs rather than only meeting the demand of the moment.
The report describes three interlocking jobs. The first is conservation and storage. CB1 activity in the brain raises appetite and the preference for dense food, and in fat tissue it favors making and storing fat. In a world of intermittent plenty that is useful. In a world of continuous surplus, with the signal left on, the same logic pushes toward steady weight gain.
The second is throttling of the mitochondria themselves. CB1 on the mitochondrial membrane lowers the activity of the first complex in the energy chain and reduces local respiration. In brief, moderate pulses this can limit reactive oxygen and protect a cell under load. Left on for long periods, it suppresses the energy sensor AMPK and the master regulator of new mitochondria, and the cell builds fewer of them. The same pathway that protects in pulses becomes a drag on oxidative capacity when it never switches off.
The third is recovery and protection from overexcitation. CB1 signaling sent backward across a synapse limits excessive transmitter release and the energy cost of a runaway network. Normal tone can also ease entry into deep slow-wave sleep, the window in which adenosine is cleared and worn mitochondria are turned over.
When the signal stays on
The report's central claim is about shape rather than substance. When the system is activated in brief pulses and followed by recovery, food, and a proper night, it can protect capacity, ease the way into restorative sleep, and steer surplus into storage without wearing itself out. When the signal is chronic, mistimed, or never followed by recovery, the same pathways produce something else: receptors that turn themselves down, an appetite and storage drive that never resolves, fewer new mitochondria, fragmented sleep, and the pattern later labeled metabolic disease or dependence.
This is the general rule of hormesis, the biology of small stresses followed by repair. Exercise, fasting, cold, heat, and well-timed caffeine all fit it. Long-term benefit appears only if the body then clears damaged parts, builds new ones, restores its energy charge, and lets receptor sensitivity return during rest. The same molecule that supports capacity in short pulses becomes, under constant or badly timed exposure, a marker of energy management that never finished its job.
Not a growth switch
A common shortcut treats cannabinoids as switches for the growth and repair programs in the cell. The report rejects it. The growth sensor mTOR is the cell's nutrient-and-growth integrator, and the cannabinoid system is not part of it. CB1 can bias that sensor toward building when energy and nutrients look available, partly by lowering AMPK, which removes a brake. But the direction depends on tissue, duration, and dose, and brain and body can move in opposite directions under long exposure. A training week that separates a growth day from repair days is set by real load and the timing of meals, not by a plant product assigned to a calendar day. The report states it outright: assigning cannabinoids to either side would add leftover receptor tone, appetite and sleep effects, and desensitization on top of a week already timed by load and feeding.
Timing and the night
The system keeps time. Components of it follow the daily clock, and the receptor is present in the brain's master clock. In the report's account, 2-AG falls to its low point near the middle of sleep and peaks in the early to mid afternoon. That is why mistimed occupancy matters. Evening or overnight receptor activity can fragment the window in which adenosine is cleared and damaged mitochondria are removed, the same causal shape as late caffeine or late nicotine. Morning light, consistent sleep timing, and a night left free of outside signals protect that window.
The cleanest way to raise the body's own cannabinoid tone is the oldest one. Real physical work produces a natural rise after effort, the runner's-high window, and then the signal clears. That is the conservation and recovery signal working as designed, under the same rule as other short stimuli: brief, linked to activity, and off before the night.
Where it fits
Nothing about this system replaces the basic work. Food rich in nutrients, including animal foods and fermented foods, supports the pools recovery draws on; that is discussed under fuel. A consistent daily rhythm, with morning light and dark nights, protects the recovery window. Progressive strength work and steady aerobic effort generate the honest demand that the body's own signals are built to answer. If cannabinoid modulation is ever discussed at all, the report places it under physician care, as secondary, and never at the cost of rest or proper food.
The evidence base is thin in a specific way. Population data are dominated by recreational, high-potency use, often mixed with smoke and continuous exposure, or by trials designed to suppress symptoms rather than to measure recovery. Controlled human evidence for long-term effects of any cannabinoid on mitochondrial markers or healthy aging is sparse, and the most interesting brain-versus-body findings so far come largely from rodents. Findings in rodents or isolated cells, the report notes, "do not establish a safe or effective human regimen."
The neighboring essay on rapamycin describes another conservation signal, the cell's growth-and-repair oscillation, that helps only when it is allowed to swing. The common thread is simple. Generate the demand through real work, let the body's own signals rise and fall, and protect the night.
For the full argument, read the extended report on endocannabinoids. The short version is in the lessons. Talk with your own physician before changing medications or supplements.
A working hypothesis, open to correction and revised as new evidence arrives. Last revised October 17, 2026.
See the notice at the top of this page. Working hypothesis, not medical advice. Natural ECS in EnSurf; exogenous cannabinoids not recommended.